S. Anders, P. T. Pyl, and W. Huber, HTSeq -A Python framework to work with high-throughput sequencing data, Bioinformatics, vol.31, pp.166-169, 2015.

P. Arnaud, K. Hata, M. Kaneda, E. Li, H. Sasaki et al., Stochastic imprinting in the progeny of Dnmt3L-/-females, Hum Mol Genet, vol.15, pp.589-598, 2006.
URL : https://hal.archives-ouvertes.fr/hal-01934553

S. B. Baylin and P. A. Jones, Epigenetic Determinants of Cancer, Cold Spring Harb Perspect Biol, vol.8, p.19505, 2016.

E. Becket, S. Chopra, C. E. Duymich, J. J. Lin, J. S. You et al., Identification of DNA Methylation-Independent Epigenetic Events Underlying Clear Cell Renal Cell Carcinoma, Cancer Res, vol.76, pp.1954-1964, 2016.

B. E. Bernstein, T. S. Mikkelsen, X. Xie, M. Kamal, D. J. Huebert et al., A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells, Cell, vol.125, pp.315-326, 2006.

S. A. Bert, M. D. Robinson, D. Strbenac, A. L. Statham, J. Z. Song et al., Regional activation of the cancer genome by long-range epigenetic remodeling, Cancer Cell, vol.23, pp.9-22, 2013.

N. P. Blackledge, A. M. Farcas, T. Kondo, H. W. King, J. F. Mcgouran et al., Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and polycomb domain formation, Cell, vol.157, pp.1445-1459, 2014.

C. W. Brennan, R. Verhaak, A. Mckenna, B. Campos, H. Noushmehr et al., The somatic genomic landscape of glioblastoma, Cell, vol.155, pp.462-477, 2013.

A. B. Brinkman, H. Gu, S. Bartels, Y. Zhang, F. Matarese et al., Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk, Genome Res, vol.22, pp.1128-1138, 2012.

S. Bruggeman, D. Hulsman, and M. Van-lohuizen, Bmi1 deficient neural stem cells have increased integrin dependent adhesion to self-secreted matrix, Biochim Biophys Acta, vol.1790, pp.351-360, 2009.

M. Ceccarelli, F. P. Barthel, T. M. Malta, T. S. Sabedot, S. R. Salama et al., Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma, Cell, vol.164, pp.550-563, 2016.

E. Cerami, J. Gao, U. Dogrusoz, B. E. Gross, S. O. Sumer et al., The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov, vol.2, pp.401-404, 2012.

Z. Chen, H. Hu, C. Zhang, C. Lu, Y. Bao et al., Downregulation of long non-coding RNA FOXD3 antisense RNA 1 (FOXD3-AS1) inhibits cell proliferation, migration, and invasion in malignant glioma cells, Am J Transl Res, vol.8, pp.4106-4119, 2016.

A. L. Cohen, S. L. Holmen, and H. Colman, IDH1 and IDH2 mutations in gliomas, Curr Neurol Neurosci Rep, vol.13, p.345, 2013.

F. Court and P. Arnaud, An annotated list of bivalent chromatin regions in human ES cells: a new tool for cancer epigenetic research, Oncotarget, vol.8, pp.4110-4124, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01917297

F. Court, C. Tayama, V. Romanelli, A. Martin-trujillo, I. Iglesias-platas et al., Genome-wide parent-of-origin DNA methylation analysis reveals the intricacies of human imprinting and suggests a germline methylation-independent mechanism of establishment, Genome Res, vol.24, pp.554-569, 2014.

M. A. Dawson, The cancer epigenome: Concepts, challenges, and therapeutic opportunities, Science, vol.355, pp.1147-1152, 2017.

A. M. Deaton and A. Bird, CpG islands and the regulation of transcription, Genes Dev, vol.25, pp.1010-1022, 2011.

S. Deneberg, P. Guardiola, A. Lennartsson, Y. Qu, V. Gaidzik et al., Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks, Blood, vol.118, pp.5573-5582, 2011.

A. Dobrovic and D. Simpfendorfer, Methylation of the BRCA1 gene in sporadic breast cancer, Cancer Res, vol.57, pp.3347-3350, 1997.

X. Dong, Q. Deng, X. Nie, M. Zhang, W. Jia et al., Downregulation of HTATIP2 expression is associated with promoter methylation and poor prognosis in glioma, Exp Mol Pathol, vol.98, pp.192-199, 2015.

E. Dudziec, A. Gogol-döring, V. Cookson, W. Chen, and J. Catto, Integrated epigenome profiling of repressive histone modifications, DNA methylation and gene expression in normal and malignant urothelial cells, PLoS ONE, vol.7, p.32750, 2012.

F. Fang, S. Turcan, A. Rimner, A. Kaufman, D. Giri et al., Breast cancer methylomes establish an epigenomic foundation for metastasis, Sci Transl Med, vol.3, pp.75-100, 2011.

A. M. Farcas, N. P. Blackledge, I. Sudbery, H. K. Long, J. F. Mcgouran et al., KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands, vol.1, p.205, 2012.

W. A. Flavahan, E. Gaskell, and B. E. Bernstein, Epigenetic plasticity and the hallmarks of cancer, Science, vol.357, p.2380, 2017.

A. Fogli, E. Chautard, C. Vaurs-barrière, B. Pereira, M. Müller-barthélémy et al., The tumoral A genotype of the MGMT rs34180180 singlenucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival, Carcinogenesis, vol.37, pp.169-176, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01629349

M. Gallo, J. Ho, F. J. Coutinho, R. Vanner, L. Lee et al., A tumorigenic MLL-homeobox network in human glioblastoma stem cells, Cancer Res, vol.73, pp.417-427, 2013.

E. N. Gal-yam, G. Egger, L. Iniguez, H. Holster, S. Einarsson et al., Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line, Proc Natl Acad Sci, vol.105, pp.12979-12984, 2008.

J. Gao, B. A. Aksoy, U. Dogrusoz, G. Dresdner, B. Gross et al., Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, vol.6, p.1, 2013.

V. Greger, N. Debus, D. Lohmann, W. Höpping, E. Passarge et al., Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma, Hum Genet, vol.94, pp.491-496, 1994.

M. A. Hahn, A. X. Li, X. Wu, R. Yang, D. A. Drew et al., Loss of the polycomb mark from bivalent promoters leads to activation of cancer-promoting genes in colorectal tumors, Cancer Res, vol.74, pp.3617-3629, 2014.

V. Häyry, M. Tanner, T. Blom, O. Tynninen, A. Roselli et al., Copy number alterations of the polycomb gene BMI1 in gliomas, Acta Neuropathol, vol.116, pp.97-102, 2008.

J. G. Herman, A. Umar, K. Polyak, J. R. Graff, N. Ahuja et al., Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma, Proc Natl Acad Sci, vol.95, pp.6870-6875, 1998.

C. Herrmann, B. Van-de-sande, D. Potier, and S. Aerts, i-cisTarget: an integrative genomics method for the prediction of regulatory features and cis-regulatory modules, Nucleic Acids Research, vol.40, p.114, 2012.

T. Hinoue, D. J. Weisenberger, C. Lange, H. Shen, H. Byun et al., Genome-scale analysis of aberrant DNA methylation in colorectal cancer, Genome Res, vol.22, pp.271-282, 2012.

D. W. Huang, B. T. Sherman, and R. A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources, Nature Protocols, vol.4, pp.44-57, 2009.

U. Jadhav, K. Nalapareddy, M. Saxena, N. K. O'neill, L. Pinello et al.,

, Acquired Tissue-Specific Promoter Bivalency Is a Basis for PRC2 Necessity in Adult Cells, Cell, vol.165, pp.1389-1400

K. C. Johnson, E. A. Houseman, J. E. King, V. Herrmann, K. M. Fadul et al., 5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients, Nat Commun, vol.7, p.13177, 2016.

W. J. Kent, A. S. Zweig, G. Barber, A. S. Hinrichs, and D. Karolchik, BigWig and BigBed: enabling browsing of large distributed datasets, Bioinformatics, vol.26, pp.2204-2207, 2010.

D. Kim, G. Pertea, C. Trapnell, H. Pimentel, R. Kelley et al., TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions, Genome Biology, vol.14, p.36, 2013.

R. J. Klose, S. Cooper, A. M. Farcas, N. P. Blackledge, and N. Brockdorff, Chromatin Sampling-An Emerging Perspective on Targeting Polycomb Repressor Proteins ed. W. Reik, PLoS Genetics, vol.9, p.1003717, 2013.

Y. Kondo, L. Shen, A. S. Cheng, S. Ahmed, Y. Boumber et al., Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation, Nat Genet, vol.40, pp.741-750, 2008.

S. Le, J. Josse, and F. Husson, FactoMineR: An R Package for Multivariate Analysis, Journal of Statistical Software, vol.25, pp.1-18, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00359835

H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan et al., , p.1000

, The Sequence Alignment/Map format and SAMtools, Bioinformatics, vol.25, pp.2078-2079, 2009.

Y. Li, H. Zheng, Q. Wang, C. Zhou, L. Wei et al., , 2018.

, Genome-wide analyses reveal a role of Polycomb in promoting hypomethylation of DNA methylation valleys, Genome Biol, vol.19, p.18

C. Liu, H. Wu, Y. Li, L. Shen, R. Yu et al., SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway, J Neurooncol, vol.135, pp.263-272, 2017.

J. Liu, W. Li, S. Liu, X. Zheng, L. Shi et al., Knockdown of Collagen Triple Helix Repeat Containing 1 (CTHRC1) Inhibits Epithelial-Mesenchymal Transition and Cellular Migration in Glioblastoma Cells, Oncol Res, vol.25, pp.225-232, 2017.

D. N. Louis, A. Perry, G. Reifenberger, . Deimling-a-von, D. Figarella-branger et al., The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary, Acta Neuropathol, vol.131, pp.803-820, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01479018

M. I. Love, W. Huber, and S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biology, vol.15, p.550, 2014.

S. Maupetit-mehouas, F. Court, C. Bourgne, A. Guerci-bresler, P. Cony-makhoul et al., DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+ CD15-cells in early chronic-phase chronic myeloid leukemia, Mol Oncol, vol.12, pp.814-829, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01917284

S. Maupetit-méhouas, B. Montibus, D. Nury, C. Tayama, M. Wassef et al., Imprinting control regions (ICRs) are marked by mono-allelic bivalent chromatin when transcriptionally inactive, Nucleic Acids Research, vol.44, pp.621-635, 2016.

E. M. Mendenhall, R. P. Koche, T. Truong, V. W. Zhou, B. Issac et al., GCRich Sequence Elements Recruit PRC2 in Mammalian ES Cells, vol.6, p.1001244, 2010.

A. M. Mikheev, S. A. Mikheeva, L. J. Severs, C. C. Funk, L. Huang et al., Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma, Mol Oncol, vol.12, pp.1188-1202, 2018.

T. S. Mikkelsen, M. Ku, D. B. Jaffe, B. Issac, E. Lieberman et al., Genome-wide maps of chromatin state in pluripotent and lineagecommitted cells, Nature, vol.448, pp.553-560, 2007.

H. Noushmehr, D. J. Weisenberger, K. Diefes, H. S. Phillips, K. Pujara et al., Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma, Cancer Cell, vol.17, pp.510-522, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01201573

J. E. Ohm, K. M. Mcgarvey, X. Yu, L. Cheng, K. E. Schuebel et al., A Stem Cell-Like Chromatin Pattern May Predispose Tumor Suppressor Genes to DNA Hypermethylation and Silencing in Adult Cancers, Nat Genet, vol.39, pp.237-242, 2007.

D. W. Parsons, S. Jones, X. Zhang, J. Lin, R. J. Leary et al., An integrated genomic analysis of human glioblastoma multiforme, Science, vol.321, pp.1807-1812, 2008.

A. R. Quinlan and I. M. Hall, BEDTools: a flexible suite of utilities for comparing genomic features, Bioinformatics, vol.26, pp.841-842, 2010.

. R-core-team, R: A language and environment for statistical computing. R Foundation for Statistical Computing, 2016.

J. P. Reddington, S. M. Perricone, C. E. Nestor, J. Reichmann, N. A. Youngson et al., Redistribution of H3K27me3 upon DNA hypomethylation results in de-repression of Polycomb target genes, Genome Biol, vol.14, p.25, 2013.

E. M. Riising, I. Comet, B. Leblanc, X. Wu, J. V. Johansen et al., Gene silencing triggers polycomb repressive complex 2 recruitment to CpG islands genome wide, Mol Cell, vol.55, pp.347-360, 2014.

M. E. Ritchie, B. Phipson, D. Wu, Y. Hu, C. W. Law et al., limma powers differential expression analyses for RNA-sequencing and microarray studies, Nucleic Acids Research, vol.43, 2015.

M. D. Robinson, D. J. Mccarthy, and G. K. Smyth, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics, vol.26, pp.139-140, 2010.

N. Schmidt, S. Windmann, G. Reifenberger, and M. J. Riemenschneider, DNA hypermethylation and histone modifications downregulate the candidate tumor suppressor gene RRP22 on 22q12 in human gliomas, Brain Pathol, vol.22, pp.17-25, 2012.

D. Sproul, R. R. Kitchen, C. E. Nestor, J. M. Dixon, A. H. Sims et al.,

, Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns, Genome Biol, vol.13, p.84

D. Sproul and R. R. Meehan, Genomic insights into cancer-associated aberrant CpG island hypermethylation, Brief Funct Genomics, vol.12, pp.174-190, 2013.

D. Sproul, C. Nestor, J. Culley, J. H. Dickson, J. M. Dixon et al., Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer, Proc Natl Acad Sci, vol.108, pp.4364-4369, 2011.

M. Staberg, R. D. Rasmussen, S. R. Michaelsen, H. Pedersen, K. E. Jensen et al., Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B, Mol Oncol, vol.12, pp.406-420, 2018.

A. L. Statham, M. D. Robinson, J. Z. Song, M. W. Coolen, C. Stirzaker et al., Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histonemodified DNA, Genome Res, vol.22, pp.1120-1127, 2012.

M. L. Suvà, N. Riggi, and B. E. Bernstein, Epigenetic reprogramming in cancer, Science, vol.339, pp.1567-1570, 2013.

M. Suvà, N. Riggi, M. Janiszewska, I. Radovanovic, P. Provero et al., EZH2 is essential for glioblastoma cancer stem cell maintenance, Cancer Res, vol.69, pp.9211-9218, 2009.

H. Suzuki, E. Yamamoto, R. Maruyama, T. Niinuma, and M. Kai, Biological significance of the CpG island methylator phenotype, Biochem Biophys Res Commun, vol.455, pp.35-42, 2014.

C. Trapnell, B. Williams, G. Pertea, A. Mortazavi, G. Kwan et al., Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation, Nature Biotechnology, vol.28, pp.511-515, 2010.

S. Turcan, D. Rohle, A. Goenka, L. A. Walsh, F. Fang et al., IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype, Nature, vol.483, pp.479-483, 2012.

M. Weber, I. Hellmann, M. B. Stadler, L. Ramos, S. Pääbo et al., Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome, Nat Genet, vol.39, pp.457-466, 2007.

X. Wu, J. V. Johansen, and K. Helin, Fbxl10/Kdm2b recruits polycomb repressive complex 1 to CpG islands and regulates H2A ubiquitylation, Mol Cell, vol.49, pp.1134-1146, 2013.

X. Wu, Y. Wang, T. Yu, E. Nie, Q. Hu et al., Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma, Neuro-oncology, vol.19, pp.1195-1205, 2017.

M. Yan, X. Yang, H. Wang, and Q. Shao, The critical role of histone lysine demethylase KDM2B in cancer, Am J Transl Res, vol.10, pp.2222-2233, 2018.

Y. Zhang, T. Liu, C. A. Meyer, J. Eeckhoute, D. S. Johnson et al., Model-based Analysis of ChIP-Seq (MACS), Genome Biology, vol.9, p.137, 2008.

W. Zhou, P. W. Laird, and H. Shen, Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes, Nucleic Acids Res, vol.45, p.22, 2017.